Found: 3
Select item for more details and to access through your institution.
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 821, doi. 10.1007/s40257-023-00782-8
- By:
- Publication type:
- Article
Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 9, p. 2063, doi. 10.1007/s13555-022-00776-0
- By:
- Publication type:
- Article
Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263214
- By:
- Publication type:
- Article